Structural Biology

Structure-Based Drug Discovery

Structure-based drug discovery (SBDD) is a powerful approach that uses the 3D structure of biological targets—such as proteins or enzymes—to design and develop new drugs. By understanding the molecular architecture of a target, researchers can identify active sites, predict binding interactions, and design molecules that fit precisely, increasing drug specificity and efficacy. Techniques like cryo-EM, X-ray crystallography, and computational modeling play a key role in this process. SBDD significantly reduces trial-and-error in drug development, accelerates lead optimization, and is essential for creating targeted therapies with fewer side effects, making it a cornerstone of modern pharmaceutical research.